The Silicone Gel-Filled Breast Implant Controversy: Testing the Bounds of Regulatory Intervention

DSpace/Manakin Repository

The Silicone Gel-Filled Breast Implant Controversy: Testing the Bounds of Regulatory Intervention

Show simple item record

dc.contributor.advisor Hutt, Peter Barton en_US
dc.contributor.author Abrams, Karen en_US
dc.date.accessioned 2012-07-06T22:02:04Z
dc.date.issued 2004 en_US
dc.identifier.citation The Silicone Gel-Filled Breast Implant Controversy: Testing the Bounds of Regulatory Intervention (2004 Third Year Paper) en
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:8965609
dc.description.abstract Silicone gel-filled breast implants were first introduced in the United States in the 1960s and immediately gained popularity among women seeking to augment or reconstruct their breasts. However, although the Food and Drug Administration (FDA) had the authority to regulate medical devices since the 1970s, breast implants were largely unregulated until concerns about a link between the devices and connective tissue diseases surfaced in the early 1980s. In the subsequent years, thousands of plaintiffs prevailed against implant manufacturers, leading to the bankruptcy of Dow Corning and a multi-million dollar class settlement. Ultimately, the controversy resulted in a FDA ban on silicone breast implants in 1992 that still survives today. This paper examines the silicone breast implant controversy from the inception of silicone devices to the current regulatory status of breast implants in the United States. Part I describes the early uses of silicone and the introduction of silicone gel-filled breast implants in the United States. Part II examines the regulatory framework for medical devices that ultimately gave the FDA the authority to ban silicone breast implants. Part III depicts the responses to the FDA’s decision from both proponents and opponents of the use of breast implants. Parts IV and V present the scientific research concerning the safety of the devices. Finally, Part VI examines the current developments regarding silicone implants, and Part VII provides some conclusions for the future. en
dc.language.iso en_US en
dash.license LAA en_US
dc.subject Food and Drug Law en
dc.subject silicone en
dc.subject breast implants en
dc.title The Silicone Gel-Filled Breast Implant Controversy: Testing the Bounds of Regulatory Intervention en
dc.type Paper (for course/seminar/workshop) en_US
dc.date.available 2012-07-06T22:02:04Z

Files in this item

Files Size Format View
Abrams.pdf 381.6Kb PDF View/Open
Abrams.rtf 410.1Kb RTF file View/Open
Abrams.html 196.1Kb HTML View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters